Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy.
Okamoto
Hideki
H
Shimizu
Eiji
E
Ozawa
Kimiyoshi
K
Hashimoto
Kenji
K
Iyo
Masaomi
M
D000928:Antidepressive Agents / Q000008:administration & dosage*; D003521:Cyclopropanes / Q000008:administration & dosage*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage*; D008875:Middle Aged; D000078764:Milnacipran; D055502:Secondary Prevention
D000928:Antidepressive Agents; D003521:Cyclopropanes; D016651:Lithium Carbonate; D000078764:Milnacipran